Chinese Medicine Times : Keeping You Informed

Chinese Medicine Times : Keeping You Informed

Chinese Scientists Win U.S. Award for Cancer Research

Source: http://english.cri.cn/6909/2012/03/07/3123s685399.htm

Two Chinese scientists were granted a top U.S. award Tuesday for innovative research that led to a new therapeutic approach to acute promyelocytic leukemia (APL).

Wang Zhenyi, 88, and Chen Zhu, 59, won the Seventh Szent Gyorgyi Prize, which was established by the U.S. National Foundation for Cancer Research (NFCR).

By combining traditional Chinese medicine with Western medicine, the two scientists created dramatic improvement in the "five-year disease-free" survival rate of APL patients -- from approximately 25 percent to 95 percent. Their therapy is now a standard for APL treatment throughout the world and has turned one of the most fatal diseases into a highly curable one.

"The Szent Gyorgyi Prize is about breakthroughs in cancer research, breakthroughs that are making possible new approaches to treating cancer, breakthroughs that are getting millions around the world promises, raising our hopes that cancer will be cured," NFCR President Franklin Salisbury told audience at the award ceremony.

A clinical researcher at the Ruijin Hospital in Shanghai in the early 1980s, Wang performed the first successful therapy on APL patients using all-trans retinoic acid (ATRA), which significantly increased the survival rate of APL patients.

Chen, Wang's former student, made major contributions to the identification of the molecular mechanisms of both ATRA and arsenic trioxide in the APL. He also demonstrated in clinical trials that arsenic trioxide, a compound used as a traditional Chinese medicine for more than 2,400 years, is effective against the APL.

Since the 1990s, Wang and Chen have worked together to conduct clinical trials combining ATRA and arsenic trioxide to treat APL patients.

"I fully understand that any achievement is the result of team work and very often continuous efforts of generations," said Chen, who is also China's health minister.

The NFCR is a leading charity dedicated to funding cancer research and public education relating to cancer prevention, earlier diagnosis, better treatments and, ultimately, cures for cancer.

Since 1973, the NFCR has provided about 300 million U.S. dollars in direct support to discovery-oriented cancer research focused on understanding how and why cells become cancerous, and on public education related to cancer prevention, detection, and treatment.

Back To Latest Articles and News

Email This Page
Discuss This

Subscribe To CMT

Shopping Basket

Your basket is empty!

Recently Viewed Login Register

Change Language

Change Currency

Subscribe to our RSS Feed Chinese Medicine Times Facebook Fan Page Chinese Medicine Times Twitter Page Chinese Medicine Times Linkedin Page Email a friend about this website
  • Chinese Herbal Formulas: Treatment Principles and Composition Strategies
  • Cupping Advert General
  • The Treatment of Pain with Chinese Herbs and Acupuncture, 2nd edition
  • AcuGlide Needle Offer
  • Acumaster Offer
  • Vinco Needle Offer
  • Viva Offer

Events Calendar

Auricular Medicine Class II: Auricular points by Dr.Li-Chun Huang (12/6/14-12/7/14)

WEBINAR: The human ear is a poweful tool for both diagnosis and treatment... [more]

National Acupuncture Detox Association Protocol Training ( April 25th-27th)

Thousands of behavioral health treatment and criminal justice... [more]

View Events Calendar

From Our Store

Ted Kaptchuk Interview

Ted Kaptchuk Interview

Ted Kaptchuk graduated wi...
Bollmann Assista Case, Black

Bollmann Assista Case, Black

Karl Bollmann of Germany ...
Premium Gua Sha Set - 9 Pieces

Premium Gua Sha Set - 9 Pieces

Complete gua sha set
Acupuncture in Practice

Acupuncture in Practice

by Hugh MacPherson and Te...
Herbs In The Treatment Of Children

Herbs In The Treatment Of Children

by Julian Scott and Teres...
Fingertoe Therapy

Fingertoe Therapy

by Jaewoo Park
Aiding the Tibetans

Aiding the Tibetans

by Subhuti Dharmananda